Condensed Statement Of Cash Flows	3 Months Ended	5 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2021 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (4,711,666)	$ (4,754,704)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest income earned on Trust Account		(4,574)
Loss upon issuance of private placement warrants	4,256,000	4,256,000
Offering costs associated with derivative warrant liabilities	40,524	40,524
Change in fair value of derivative warrant liabilities	336,000	336,000
Changes in operating assets and liabilities:
Prepaid expenses		(1,039,267)
Franchise tax payable		88,817
Accounts payable		1,014,750
Accrued expenses		(6,181)
Net cash provided by operating activities		(68,635)
Cash Flows from Investing Activities
Cash deposited in Trust Account		(234,600,000)
Net cash used in investing activities		(234,600,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor		25,000
Proceeds from note payable to related party		300,000
Repayment of note payable to related party		(300,000)
Proceeds received from initial public offering, gross		230,000,000
Proceeds received from private placement		11,200,000
Offering costs paid		(5,095,674)
Net cash used by financing activities		236,129,326
Net increase in cash		1,460,691
Cash - beginning of the period		0
Cash - end of the period	1,460,691	1,460,691
Supplemental disclosure of noncash activities:
Offering costs included in accounts payable		15,000
Offering costs included in accrued expenses		132,563
Deferred underwriting commissions in connection with the Initial Public Offering	8,050,000	8,050,000
Accretion of Class A common stock subject to possible redemption	$ 17,852,712	$ 17,852,712